Prognostic and Predictive Role of PD-L1 Expression in Stage III NSCLC Treated With Definitive Chemoradiation and Adjuvant Durvalumab
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
International Journal of Radiation Oncology, Biology, Physics
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Prognostic and Predictive Role of PD-L1 Expression in Stage III Non-small Cell Lung Cancer Treated With Definitive Chemoradiation and Adjuvant Durvalumab
Int. J. Radiat. Oncol. Biol. Phys 2022 Apr 18;[EPub Ahead of Print], AK Bryant, K Sankar, GW Strohbehn, L Zhao, V Daniel, D Elliott, N Ramnath, MD GreenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.